SCHEMBL30494162

SCHEMBL30494162

CSC1=N/C(=C\c2ccc3[nH]cnc3c2)C(=O)N1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.56
▸ CYP1A2 P05177 2/20 0.55
▸ CYP3A4 P08684 2/20 0.55
▸ CYP2C19 P33261 2/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ CBS P35520 1/20 0.55
▸ DYRK2 Q92630 9/20 0.43
▸ DYRK3 O43781 5/20 0.43
▸ DYRK1A Q13627 5/20 0.43
▸ DYRK1B Q9Y463 5/20 0.43
▸ PIM1 P11309 5/20 0.43
▸ GAA P10253 1/20 0.41
▸ MAPK1 P28482 1/20 0.40
▸ CLK1 P49759 2/20 0.39
▸ CLK2 P49760 2/20 0.39
▸ GSK3A P49840 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ LTB4R Q15722 1/20 0.39
▸ CLK4 Q9HAZ1 1/20 0.39
▸ DYRK4 Q9NR20 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30494268 0.77 MAPT (0.56) MAPTCYP1A2CYP3A4CYP2C19CYP2C9
SCHEMBL30494355 0.76 MAPT (0.58) MAPTCYP1A2CYP3A4CYP2C19CYP2C9
SCHEMBL30494101 0.75 MAPT (0.57) MAPTCYP1A2CYP3A4CYP2C19CYP2C9
SCHEMBL30494209 0.75 DYRK2 (0.40) DYRK2DYRK3DYRK1ADYRK1BPIM1
SCHEMBL30494062 0.75 DYRK2 (0.45) MAPTCYP1A2CYP2C19CYP2C9DYRK2
SCHEMBL30494396 0.75 DYRK2 (0.40) DYRK2DYRK3DYRK1ADYRK1BPIM1
SCHEMBL30363432 0.74 MAPT (0.60) MAPTCYP1A2CYP3A4CYP2C19CYP2C9
SCHEMBL30396066 0.74 MAPT (0.56) MAPTCYP1A2CYP3A4CYP2C19CYP2C9
SCHEMBL30363334 0.74 MAPT (0.55) MAPTCYP1A2CYP3A4CYP2C19CYP2C9
SCHEMBL30494037 0.71 IDH1 (0.58) MAPTGAAALDH1A1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4422753-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 Perha Pharmaceuticals (FR) 2024-09-04 — — EP disclosed
WO-2023072966-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 PERHA PHARMACEUTICALS (FR) 2023-05-04 — — WO disclosed
Send feedback